metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Evaluation of the hepatoprotective effect of an hydroalcoholic extract of Jatrop...
Información de la revista
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S2.
Abstracts Asociación Mexicana del Hígado (AMH) 2023
(febrero 2024)
Acceso a texto completo
Evaluation of the hepatoprotective effect of an hydroalcoholic extract of Jatropha dioica against the damage induced by valproic acid in Wistar rats
Visitas
169
Ramiro Tijerina-Márquez1,2, Oscar H. Mendoza-Hernández1, César B. Espinosa-Cantú1, Verónica M Rivas-Galindo3, Diana Moreno-Peña1, Liliana Torres-González3, Linda E. Muñoz-Espinosa1, Edelmiro Pérez-Rodríguez4, Idalia A. Cura-Esquivel5, Paula Cordero-Pérez1
1 Liver unit, Internal Medicine Department, University Hospital ''Dr. José Eleuterio González'', Universidad Autónoma de Nuevo León, Monterrey, Nuevo León
2 Fellow within the Dirección General de Calidad y Educación en Salud, Secretaría de Salud, México
3 Analytic Chemistry Department, School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León
4 Organ and Tissue Transplant Service, Department of General Surgery, University Hospital ''Dr. José Eleuterio González'', Universidad Autónoma de Nuevo León, Monterrey, Nuevo León
5 Department of Pediatrics, University Hospital ''Dr. José Eleuterio González'', Universidad Autónoma de Nuevo León, Monterrey, Nuevo León
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (2)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

Más datos
Introduction and Objectives

Liver diseases have gained importance due to their prevalence, incidence and because most chronic liver diseases have no cure, except for hepatitis C. Liver damage induced by drugs such as valproic acid (VPA) has been used to study therapeutic alternatives. Jatropha dioica may be one of these alternatives as it has metabolites with potential antioxidant activity. The objetive of this study was to evaluate the hepatoprotective effect of a hydroalcoholic extract of J. dioica against VPA-induced damage in Wistar rats.

Materials and Patients

24 Wistar rats of both sexes were used. Groups: Sham (SH), Non-Toxicity(JdTox), VPA and J. dioica+VPA(JdVPA) (n=6). J. dioica (300 mg/kg, p.o) was administered for 7 days, followed by VPA (500 mg/kg, i.p, for four days) injected concomitantly. Biochemical markers, oxidative stress, and histological analysis were determined. Ethics Committee approval under HI22-00003 registry and PAICYT 143-CS-2022 financing. The research group declares no conflict of interest.

Results

VPA group showed a significant increase in ALT and AST against Sham, JdVPA group showed a significant decrease in these parameters vs. VPA (Figure 1), and the remaining biochemical markers showed no statistically significant differences between the groups. The VPA group presented statistically significant alterations in the concentrations of malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD) vs. SH. The JdVPA group significantly improved the damage caused by VPA, decreasing MDA and increasing GSH and SOD (Figure 2). Histologically, VPA presented an inflammatory infiltrate, which decreased in the JdVPA group. However, this difference was not statistically significant.

Conclusions

In murine models, VPA has been able to induce alterations in transaminase levels and oxidative stress markers, both of which may indicate the presence of liver damage. Plants of the Jatropha genus have been shown to possess phenolic and flavonoid compounds with antioxidant capacity, which may be responsible for the hepatoprotective effect observed in this study using J. dioica at the evaluated dose without showing toxicity.

Texto completo

Ethical statement

The protocol was registered and approved by the Ethics Committee.

Declaration of interests

None

Funding

Funding for this project came from PAICYT under registration number 143-CS-2022.

Figure 1. Serum biochemical markers. (A) Serum ALT levels, *P = 0.036 vs. SH, † P= 0.0015 vs. AVP-C. (B) Serum AST levels, *P<0.0001 vs. SH, #P<0.0001 vs. JdTox, †P<0.0001 vs. AVP-C. (C) Serum LDH levels, #P < 0.0498 vs. JdTox. Kruskal-Wallis with Dunn's post hoc (A) and One-way ANOVA with Tukey's post-hoc (B-C)

Figure 2. Liver tissue concentrations of oxidative stress biomarkers. (D) MDA, *P = 0.0012 vs. SH, † P= 0.0283 vs. AVP-C. (E) SOD, *P < 0.0001 vs. SH, #P < 0.0001 vs. JdTox, †P < 0.0003 vs. AVP-C. (F) GSH, * P < 0.007 vs. SH, # P =0.0007 vs. JdTox, † P=0.0221 vs. AVP-C. One-way ANOVA with Tukey's post-hoc (A-C)

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos